CHE Stock Chart & Stats
$8346.31
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$7,908.91 - $9,083.33
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$118.63B
Enterprise Value$5.40K
Total Cash (Recent Filing)$16.86M
Total Debt (Recent Filing)$236.93M
Price to Earnings (P/E)27.8
Beta-0.04
Next Earnings
Jul 28, 2026EPS Estimate
98.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)18.39
Shares Outstanding13,274,104
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.78
Price to Book (P/B)6.29
Price to Sales (P/S)2.43
P/FCF Ratio18.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8,281.68Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent, large operating and free cash flows provide durable financial flexibility: they fund acquisitions (franchise buybacks), share repurchases, reinvestment, and buffer seasonality. High cash conversion also supports sustained capital allocation without increasing leverage.
Conservative Leverage And High ROEVery low debt-to-equity and strong ROE indicate capital efficiency and low interest burden. This conservative capital structure supports resilience in downturns, capacity for bolt-on M&A or franchise repurchases, and long-term investment without risking solvency or large refinancing needs.
VITAS: Durable Demand And Upgraded GuidanceVITAS’s raised ADC, revenue and margin guidance reflects durable end‑of‑life care demand and operational leverage. Given aging demographics and stable payor relationships, stronger admissions and improved margins underpin sustainable cash flow and lower execution risk at the company level.
Bears Say
Roto‑Rooter Margin Pressure From MarketingElevated customer acquisition costs are a structural headwind for a transactional services business. If paid leads remain a larger share of volume, sustained higher marketing will compress Roto‑Rooter margins, forcing price, efficiency, or mix changes to restore long‑term profitability.
VITAS Shorter Length Of Stay And Mix ShiftA persistent decline in length of stay and shifts toward shorter‑stay patients reduce revenue per admission and can worsen reimbursement mix. Over time, this trend pressures revenue growth and margin durability unless offset by higher admissions, pricing, or improved acuity management.
Governance Risk: Say‑on‑pay RejectedA failed advisory vote on pay signals investor dissatisfaction and raises governance scrutiny. That can force compensation redesign, invite activist engagement, or constrain management incentives, potentially distracting leadership from long‑term strategy and affecting retention or execution.
CHE FAQ
What was Chemed’s price range in the past 12 months?
Chemed lowest stock price was $7908.91 and its highest was $9083.33 in the past 12 months.
What is Chemed’s market cap?
Chemed’s market cap is $118.63B.
When is Chemed’s upcoming earnings report date?
Chemed’s upcoming earnings report date is Jul 28, 2026 which is in 3 days.
How were Chemed’s earnings last quarter?
Chemed released its earnings results on Apr 23, 2026. The company reported $98.925 earnings per share for the quarter, beating the consensus estimate of $92.832 by $6.093.
Is Chemed overvalued?
According to Wall Street analysts Chemed’s price is currently Undervalued.
Does Chemed pay dividends?
Chemed does not currently pay dividends.
What is Chemed’s EPS estimate?
Chemed’s EPS estimate is 98.05.
How many shares outstanding does Chemed have?
Chemed has 13,274,104 shares outstanding.
What happened to Chemed’s price movement after its last earnings report?
Chemed reported an EPS of $98.925 in its last earnings report, beating expectations of $92.832. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Chemed?
Currently, no hedge funds are holding shares in MX:CHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8,281.68 (― Downside)
$8,281.68 (― Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.49%
12-Months-Change
Fundamentals
Return on Equity
0.55%
Trailing 12-Months
Asset Growth
-11.05%
Trailing 12-Months
Company Description
Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Stock 12 Month Forecast
Average Price Target
$8,281.68